nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP19A1—Tamoxifen—pancreatic cancer	0.252	0.381	CbGbCtD
Letrozole—CYP2A6—Tamoxifen—pancreatic cancer	0.16	0.241	CbGbCtD
Letrozole—CYP2A6—Fluorouracil—pancreatic cancer	0.118	0.178	CbGbCtD
Letrozole—CYP3A4—Tamoxifen—pancreatic cancer	0.032	0.0482	CbGbCtD
Letrozole—CYP3A4—Erlotinib—pancreatic cancer	0.0272	0.041	CbGbCtD
Letrozole—CYP3A4—Irinotecan—pancreatic cancer	0.0245	0.037	CbGbCtD
Letrozole—CYP3A4—Docetaxel—pancreatic cancer	0.018	0.0271	CbGbCtD
Letrozole—CYP3A4—Sunitinib—pancreatic cancer	0.0179	0.027	CbGbCtD
Letrozole—CYP3A4—Doxorubicin—pancreatic cancer	0.0134	0.0202	CbGbCtD
Letrozole—Constipation—Gemcitabine—pancreatic cancer	0.000204	0.000605	CcSEcCtD
Letrozole—Nausea—Erlotinib—pancreatic cancer	0.000204	0.000605	CcSEcCtD
Letrozole—Decreased appetite—Fluorouracil—pancreatic cancer	0.000204	0.000605	CcSEcCtD
Letrozole—Diarrhoea—Sunitinib—pancreatic cancer	0.000204	0.000604	CcSEcCtD
Letrozole—Dysgeusia—Docetaxel—pancreatic cancer	0.000203	0.000603	CcSEcCtD
Letrozole—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000203	0.000601	CcSEcCtD
Letrozole—Feeling abnormal—Irinotecan—pancreatic cancer	0.000202	0.000599	CcSEcCtD
Letrozole—Influenza—Epirubicin—pancreatic cancer	0.000201	0.000596	CcSEcCtD
Letrozole—Back pain—Docetaxel—pancreatic cancer	0.000201	0.000596	CcSEcCtD
Letrozole—Pain—Fluorouracil—pancreatic cancer	0.000201	0.000595	CcSEcCtD
Letrozole—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.0002	0.000594	CcSEcCtD
Letrozole—Dry skin—Doxorubicin—pancreatic cancer	0.000197	0.000585	CcSEcCtD
Letrozole—Dizziness—Sunitinib—pancreatic cancer	0.000197	0.000584	CcSEcCtD
Letrozole—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000197	0.000583	CcSEcCtD
Letrozole—Angina pectoris—Epirubicin—pancreatic cancer	0.000196	0.000581	CcSEcCtD
Letrozole—Breast disorder—Doxorubicin—pancreatic cancer	0.000194	0.000577	CcSEcCtD
Letrozole—Body temperature increased—Irinotecan—pancreatic cancer	0.000194	0.000575	CcSEcCtD
Letrozole—Abdominal pain—Irinotecan—pancreatic cancer	0.000194	0.000575	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000194	0.000575	CcSEcCtD
Letrozole—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000193	0.000574	CcSEcCtD
Letrozole—Vomiting—Sunitinib—pancreatic cancer	0.000189	0.000561	CcSEcCtD
Letrozole—Body temperature increased—Gemcitabine—pancreatic cancer	0.000189	0.00056	CcSEcCtD
Letrozole—Rash—Sunitinib—pancreatic cancer	0.000188	0.000556	CcSEcCtD
Letrozole—Dermatitis—Sunitinib—pancreatic cancer	0.000187	0.000556	CcSEcCtD
Letrozole—Urticaria—Fluorouracil—pancreatic cancer	0.000186	0.000553	CcSEcCtD
Letrozole—Headache—Sunitinib—pancreatic cancer	0.000186	0.000553	CcSEcCtD
Letrozole—Influenza—Doxorubicin—pancreatic cancer	0.000186	0.000551	CcSEcCtD
Letrozole—Leukopenia—Docetaxel—pancreatic cancer	0.000186	0.000551	CcSEcCtD
Letrozole—Pollakiuria—Epirubicin—pancreatic cancer	0.000186	0.000551	CcSEcCtD
Letrozole—Body temperature increased—Fluorouracil—pancreatic cancer	0.000186	0.00055	CcSEcCtD
Letrozole—Palpitations—Docetaxel—pancreatic cancer	0.000183	0.000544	CcSEcCtD
Letrozole—Weight increased—Epirubicin—pancreatic cancer	0.000183	0.000542	CcSEcCtD
Letrozole—Weight decreased—Epirubicin—pancreatic cancer	0.000182	0.000539	CcSEcCtD
Letrozole—Cough—Docetaxel—pancreatic cancer	0.000181	0.000537	CcSEcCtD
Letrozole—Angina pectoris—Doxorubicin—pancreatic cancer	0.000181	0.000537	CcSEcCtD
Letrozole—Hypertension—Docetaxel—pancreatic cancer	0.000179	0.000532	CcSEcCtD
Letrozole—Infestation—Epirubicin—pancreatic cancer	0.000179	0.000531	CcSEcCtD
Letrozole—Infestation NOS—Epirubicin—pancreatic cancer	0.000179	0.000531	CcSEcCtD
Letrozole—Arthralgia—Docetaxel—pancreatic cancer	0.000177	0.000524	CcSEcCtD
Letrozole—Chest pain—Docetaxel—pancreatic cancer	0.000177	0.000524	CcSEcCtD
Letrozole—Myalgia—Docetaxel—pancreatic cancer	0.000177	0.000524	CcSEcCtD
Letrozole—Nausea—Sunitinib—pancreatic cancer	0.000177	0.000524	CcSEcCtD
Letrozole—Asthenia—Irinotecan—pancreatic cancer	0.000176	0.000521	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000175	0.000521	CcSEcCtD
Letrozole—Stomatitis—Epirubicin—pancreatic cancer	0.000175	0.000518	CcSEcCtD
Letrozole—Urinary tract infection—Epirubicin—pancreatic cancer	0.000174	0.000517	CcSEcCtD
Letrozole—Dry mouth—Docetaxel—pancreatic cancer	0.000173	0.000513	CcSEcCtD
Letrozole—Sweating—Epirubicin—pancreatic cancer	0.000172	0.000509	CcSEcCtD
Letrozole—Pollakiuria—Doxorubicin—pancreatic cancer	0.000172	0.000509	CcSEcCtD
Letrozole—Asthenia—Gemcitabine—pancreatic cancer	0.000171	0.000508	CcSEcCtD
Letrozole—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000169	0.000503	CcSEcCtD
Letrozole—Oedema—Docetaxel—pancreatic cancer	0.000169	0.000502	CcSEcCtD
Letrozole—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000169	0.000502	CcSEcCtD
Letrozole—Weight increased—Doxorubicin—pancreatic cancer	0.000169	0.000502	CcSEcCtD
Letrozole—Pruritus—Gemcitabine—pancreatic cancer	0.000169	0.000501	CcSEcCtD
Letrozole—Infection—Docetaxel—pancreatic cancer	0.000168	0.000499	CcSEcCtD
Letrozole—Weight decreased—Doxorubicin—pancreatic cancer	0.000168	0.000499	CcSEcCtD
Letrozole—Diarrhoea—Irinotecan—pancreatic cancer	0.000168	0.000497	CcSEcCtD
Letrozole—Nervous system disorder—Docetaxel—pancreatic cancer	0.000166	0.000493	CcSEcCtD
Letrozole—Pruritus—Fluorouracil—pancreatic cancer	0.000166	0.000493	CcSEcCtD
Letrozole—Infestation—Doxorubicin—pancreatic cancer	0.000166	0.000492	CcSEcCtD
Letrozole—Infestation NOS—Doxorubicin—pancreatic cancer	0.000166	0.000492	CcSEcCtD
Letrozole—Tachycardia—Docetaxel—pancreatic cancer	0.000165	0.00049	CcSEcCtD
Letrozole—Skin disorder—Docetaxel—pancreatic cancer	0.000165	0.000488	CcSEcCtD
Letrozole—Diarrhoea—Gemcitabine—pancreatic cancer	0.000163	0.000484	CcSEcCtD
Letrozole—Dizziness—Irinotecan—pancreatic cancer	0.000162	0.000481	CcSEcCtD
Letrozole—Haemoglobin—Epirubicin—pancreatic cancer	0.000162	0.000479	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—pancreatic cancer	0.000162	0.000479	CcSEcCtD
Letrozole—Anorexia—Docetaxel—pancreatic cancer	0.000161	0.000479	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000161	0.000478	CcSEcCtD
Letrozole—Haemorrhage—Epirubicin—pancreatic cancer	0.000161	0.000477	CcSEcCtD
Letrozole—Hepatitis—Epirubicin—pancreatic cancer	0.000161	0.000477	CcSEcCtD
Letrozole—Diarrhoea—Fluorouracil—pancreatic cancer	0.000161	0.000476	CcSEcCtD
Letrozole—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00016	0.000475	CcSEcCtD
Letrozole—Sweating—Doxorubicin—pancreatic cancer	0.000159	0.000471	CcSEcCtD
Letrozole—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000159	0.000471	CcSEcCtD
Letrozole—Oedema peripheral—Epirubicin—pancreatic cancer	0.000158	0.00047	CcSEcCtD
Letrozole—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000158	0.000469	CcSEcCtD
Letrozole—Urethral disorder—Epirubicin—pancreatic cancer	0.000158	0.000468	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000157	0.000465	CcSEcCtD
Letrozole—Vomiting—Irinotecan—pancreatic cancer	0.000156	0.000462	CcSEcCtD
Letrozole—Dizziness—Fluorouracil—pancreatic cancer	0.000155	0.00046	CcSEcCtD
Letrozole—Rash—Irinotecan—pancreatic cancer	0.000155	0.000458	CcSEcCtD
Letrozole—Dermatitis—Irinotecan—pancreatic cancer	0.000154	0.000458	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000154	0.000458	CcSEcCtD
Letrozole—Headache—Irinotecan—pancreatic cancer	0.000154	0.000455	CcSEcCtD
Letrozole—Insomnia—Docetaxel—pancreatic cancer	0.000153	0.000454	CcSEcCtD
Letrozole—Paraesthesia—Docetaxel—pancreatic cancer	0.000152	0.000451	CcSEcCtD
Letrozole—Erythema multiforme—Epirubicin—pancreatic cancer	0.000152	0.000451	CcSEcCtD
Letrozole—Vomiting—Gemcitabine—pancreatic cancer	0.000152	0.00045	CcSEcCtD
Letrozole—Dyspnoea—Docetaxel—pancreatic cancer	0.000151	0.000448	CcSEcCtD
Letrozole—Somnolence—Docetaxel—pancreatic cancer	0.000151	0.000447	CcSEcCtD
Letrozole—Rash—Gemcitabine—pancreatic cancer	0.000151	0.000446	CcSEcCtD
Letrozole—Dermatitis—Gemcitabine—pancreatic cancer	0.00015	0.000446	CcSEcCtD
Letrozole—Eye disorder—Epirubicin—pancreatic cancer	0.00015	0.000446	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—pancreatic cancer	0.00015	0.000444	CcSEcCtD
Letrozole—Headache—Gemcitabine—pancreatic cancer	0.00015	0.000444	CcSEcCtD
Letrozole—Flushing—Epirubicin—pancreatic cancer	0.000149	0.000443	CcSEcCtD
Letrozole—Cardiac disorder—Epirubicin—pancreatic cancer	0.000149	0.000443	CcSEcCtD
Letrozole—Vomiting—Fluorouracil—pancreatic cancer	0.000149	0.000443	CcSEcCtD
Letrozole—Dyspepsia—Docetaxel—pancreatic cancer	0.000149	0.000442	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—pancreatic cancer	0.000149	0.000441	CcSEcCtD
Letrozole—Hepatitis—Doxorubicin—pancreatic cancer	0.000149	0.000441	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000148	0.000439	CcSEcCtD
Letrozole—Rash—Fluorouracil—pancreatic cancer	0.000148	0.000439	CcSEcCtD
Letrozole—Dermatitis—Fluorouracil—pancreatic cancer	0.000148	0.000439	CcSEcCtD
Letrozole—Decreased appetite—Docetaxel—pancreatic cancer	0.000147	0.000437	CcSEcCtD
Letrozole—Headache—Fluorouracil—pancreatic cancer	0.000147	0.000436	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000147	0.000436	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000147	0.000435	CcSEcCtD
Letrozole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000146	0.000434	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000146	0.000434	CcSEcCtD
Letrozole—Fatigue—Docetaxel—pancreatic cancer	0.000146	0.000433	CcSEcCtD
Letrozole—Angiopathy—Epirubicin—pancreatic cancer	0.000146	0.000433	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—pancreatic cancer	0.000146	0.000433	CcSEcCtD
Letrozole—Nausea—Irinotecan—pancreatic cancer	0.000146	0.000432	CcSEcCtD
Letrozole—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000145	0.00043	CcSEcCtD
Letrozole—Constipation—Docetaxel—pancreatic cancer	0.000145	0.00043	CcSEcCtD
Letrozole—Pain—Docetaxel—pancreatic cancer	0.000145	0.00043	CcSEcCtD
Letrozole—Alopecia—Epirubicin—pancreatic cancer	0.000142	0.000422	CcSEcCtD
Letrozole—Nausea—Gemcitabine—pancreatic cancer	0.000142	0.000421	CcSEcCtD
Letrozole—Mental disorder—Epirubicin—pancreatic cancer	0.000141	0.000418	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000141	0.000417	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—pancreatic cancer	0.00014	0.000415	CcSEcCtD
Letrozole—Feeling abnormal—Docetaxel—pancreatic cancer	0.00014	0.000414	CcSEcCtD
Letrozole—Nausea—Fluorouracil—pancreatic cancer	0.000139	0.000414	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—pancreatic cancer	0.000139	0.000412	CcSEcCtD
Letrozole—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000139	0.000411	CcSEcCtD
Letrozole—Flushing—Doxorubicin—pancreatic cancer	0.000138	0.00041	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000138	0.00041	CcSEcCtD
Letrozole—Tension—Epirubicin—pancreatic cancer	0.000137	0.000407	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—pancreatic cancer	0.000137	0.000407	CcSEcCtD
Letrozole—Nervousness—Epirubicin—pancreatic cancer	0.000136	0.000403	CcSEcCtD
Letrozole—Back pain—Epirubicin—pancreatic cancer	0.000135	0.000402	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—pancreatic cancer	0.000135	0.0004	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000134	0.000398	CcSEcCtD
Letrozole—Abdominal pain—Docetaxel—pancreatic cancer	0.000134	0.000397	CcSEcCtD
Letrozole—Body temperature increased—Docetaxel—pancreatic cancer	0.000134	0.000397	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—pancreatic cancer	0.000132	0.000391	CcSEcCtD
Letrozole—Alopecia—Doxorubicin—pancreatic cancer	0.000131	0.00039	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—pancreatic cancer	0.00013	0.000387	CcSEcCtD
Letrozole—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00013	0.000385	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—pancreatic cancer	0.00013	0.000384	CcSEcCtD
Letrozole—Tension—Doxorubicin—pancreatic cancer	0.000127	0.000377	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—pancreatic cancer	0.000127	0.000376	CcSEcCtD
Letrozole—Malaise—Epirubicin—pancreatic cancer	0.000126	0.000374	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—pancreatic cancer	0.000126	0.000373	CcSEcCtD
Letrozole—Vertigo—Epirubicin—pancreatic cancer	0.000126	0.000373	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—pancreatic cancer	0.000125	0.000372	CcSEcCtD
Letrozole—Back pain—Doxorubicin—pancreatic cancer	0.000125	0.000372	CcSEcCtD
Letrozole—Palpitations—Epirubicin—pancreatic cancer	0.000124	0.000367	CcSEcCtD
Letrozole—Cough—Epirubicin—pancreatic cancer	0.000122	0.000362	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—pancreatic cancer	0.000122	0.000362	CcSEcCtD
Letrozole—Asthenia—Docetaxel—pancreatic cancer	0.000122	0.00036	CcSEcCtD
Letrozole—Hypertension—Epirubicin—pancreatic cancer	0.000121	0.000359	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00012	0.000356	CcSEcCtD
Letrozole—Pruritus—Docetaxel—pancreatic cancer	0.00012	0.000355	CcSEcCtD
Letrozole—Chest pain—Epirubicin—pancreatic cancer	0.000119	0.000354	CcSEcCtD
Letrozole—Myalgia—Epirubicin—pancreatic cancer	0.000119	0.000354	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—pancreatic cancer	0.000119	0.000354	CcSEcCtD
Letrozole—Anxiety—Epirubicin—pancreatic cancer	0.000119	0.000352	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000118	0.000351	CcSEcCtD
Letrozole—Discomfort—Epirubicin—pancreatic cancer	0.000118	0.000349	CcSEcCtD
Letrozole—Malaise—Doxorubicin—pancreatic cancer	0.000117	0.000346	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—pancreatic cancer	0.000117	0.000346	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—pancreatic cancer	0.000116	0.000345	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—pancreatic cancer	0.000116	0.000344	CcSEcCtD
Letrozole—Diarrhoea—Docetaxel—pancreatic cancer	0.000116	0.000344	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—pancreatic cancer	0.000114	0.00034	CcSEcCtD
Letrozole—Oedema—Epirubicin—pancreatic cancer	0.000114	0.000339	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000114	0.000339	CcSEcCtD
Letrozole—Infection—Epirubicin—pancreatic cancer	0.000114	0.000337	CcSEcCtD
Letrozole—Cough—Doxorubicin—pancreatic cancer	0.000113	0.000335	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—pancreatic cancer	0.000112	0.000332	CcSEcCtD
Letrozole—Dizziness—Docetaxel—pancreatic cancer	0.000112	0.000332	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—pancreatic cancer	0.000112	0.000332	CcSEcCtD
Letrozole—Tachycardia—Epirubicin—pancreatic cancer	0.000112	0.000331	CcSEcCtD
Letrozole—Skin disorder—Epirubicin—pancreatic cancer	0.000111	0.000329	CcSEcCtD
Letrozole—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00011	0.000328	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—pancreatic cancer	0.00011	0.000327	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—pancreatic cancer	0.00011	0.000327	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—pancreatic cancer	0.00011	0.000327	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—pancreatic cancer	0.00011	0.000326	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00011	0.000325	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—pancreatic cancer	0.000109	0.000323	CcSEcCtD
Letrozole—Anorexia—Epirubicin—pancreatic cancer	0.000109	0.000323	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—pancreatic cancer	0.000108	0.00032	CcSEcCtD
Letrozole—Vomiting—Docetaxel—pancreatic cancer	0.000108	0.000319	CcSEcCtD
Letrozole—Rash—Docetaxel—pancreatic cancer	0.000107	0.000317	CcSEcCtD
Letrozole—Dermatitis—Docetaxel—pancreatic cancer	0.000107	0.000317	CcSEcCtD
Letrozole—Headache—Docetaxel—pancreatic cancer	0.000106	0.000315	CcSEcCtD
Letrozole—Oedema—Doxorubicin—pancreatic cancer	0.000106	0.000314	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000106	0.000314	CcSEcCtD
Letrozole—Infection—Doxorubicin—pancreatic cancer	0.000105	0.000312	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000104	0.000309	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000104	0.000308	CcSEcCtD
Letrozole—Insomnia—Epirubicin—pancreatic cancer	0.000103	0.000307	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—pancreatic cancer	0.000103	0.000306	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—pancreatic cancer	0.000103	0.000305	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—pancreatic cancer	0.000103	0.000304	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000102	0.000303	CcSEcCtD
Letrozole—Dyspnoea—Epirubicin—pancreatic cancer	0.000102	0.000302	CcSEcCtD
Letrozole—Somnolence—Epirubicin—pancreatic cancer	0.000102	0.000301	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—pancreatic cancer	0.000101	0.000299	CcSEcCtD
Letrozole—Nausea—Docetaxel—pancreatic cancer	0.000101	0.000298	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—pancreatic cancer	0.000101	0.000298	CcSEcCtD
Letrozole—Decreased appetite—Epirubicin—pancreatic cancer	9.93e-05	0.000295	CcSEcCtD
Letrozole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.86e-05	0.000293	CcSEcCtD
Letrozole—Fatigue—Epirubicin—pancreatic cancer	9.85e-05	0.000292	CcSEcCtD
Letrozole—Constipation—Epirubicin—pancreatic cancer	9.77e-05	0.00029	CcSEcCtD
Letrozole—Pain—Epirubicin—pancreatic cancer	9.77e-05	0.00029	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	9.63e-05	0.000286	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—pancreatic cancer	9.56e-05	0.000284	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—pancreatic cancer	9.49e-05	0.000282	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—pancreatic cancer	9.43e-05	0.00028	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—pancreatic cancer	9.42e-05	0.000279	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—pancreatic cancer	9.4e-05	0.000279	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.34e-05	0.000277	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—pancreatic cancer	9.31e-05	0.000276	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—pancreatic cancer	9.19e-05	0.000273	CcSEcCtD
Letrozole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	9.13e-05	0.000271	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—pancreatic cancer	9.12e-05	0.00027	CcSEcCtD
Letrozole—Urticaria—Epirubicin—pancreatic cancer	9.08e-05	0.000269	CcSEcCtD
Letrozole—Constipation—Doxorubicin—pancreatic cancer	9.04e-05	0.000268	CcSEcCtD
Letrozole—Pain—Doxorubicin—pancreatic cancer	9.04e-05	0.000268	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—pancreatic cancer	9.03e-05	0.000268	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—pancreatic cancer	9.03e-05	0.000268	CcSEcCtD
Letrozole—Feeling abnormal—Doxorubicin—pancreatic cancer	8.71e-05	0.000258	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.65e-05	0.000256	CcSEcCtD
Letrozole—Urticaria—Doxorubicin—pancreatic cancer	8.4e-05	0.000249	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—pancreatic cancer	8.36e-05	0.000248	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—pancreatic cancer	8.36e-05	0.000248	CcSEcCtD
Letrozole—Asthenia—Epirubicin—pancreatic cancer	8.2e-05	0.000243	CcSEcCtD
Letrozole—Pruritus—Epirubicin—pancreatic cancer	8.08e-05	0.00024	CcSEcCtD
Letrozole—Diarrhoea—Epirubicin—pancreatic cancer	7.82e-05	0.000232	CcSEcCtD
Letrozole—Asthenia—Doxorubicin—pancreatic cancer	7.59e-05	0.000225	CcSEcCtD
Letrozole—Dizziness—Epirubicin—pancreatic cancer	7.56e-05	0.000224	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—pancreatic cancer	7.48e-05	0.000222	CcSEcCtD
Letrozole—Vomiting—Epirubicin—pancreatic cancer	7.27e-05	0.000215	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—pancreatic cancer	7.23e-05	0.000215	CcSEcCtD
Letrozole—Rash—Epirubicin—pancreatic cancer	7.2e-05	0.000214	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—pancreatic cancer	7.2e-05	0.000213	CcSEcCtD
Letrozole—Headache—Epirubicin—pancreatic cancer	7.16e-05	0.000212	CcSEcCtD
Letrozole—Dizziness—Doxorubicin—pancreatic cancer	6.99e-05	0.000207	CcSEcCtD
Letrozole—Nausea—Epirubicin—pancreatic cancer	6.79e-05	0.000201	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—pancreatic cancer	6.72e-05	0.000199	CcSEcCtD
Letrozole—Rash—Doxorubicin—pancreatic cancer	6.67e-05	0.000198	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—pancreatic cancer	6.66e-05	0.000198	CcSEcCtD
Letrozole—Headache—Doxorubicin—pancreatic cancer	6.62e-05	0.000196	CcSEcCtD
Letrozole—Nausea—Doxorubicin—pancreatic cancer	6.28e-05	0.000186	CcSEcCtD
